On the occasion of the ASCO congress (American society of Clinical Cancer), Pr. Eric Raymond has shown the positive results of a worldwide study of immunotherapy for oesophageal cancer. When tislelizumab, a new immunotherapy antibody, is given with the usual chemotherapy, it significantly improves the patient survival with a 34% lower risk of death.
On the occasion of the 53rd anniversary of the victory of October 6, 1973 commemorated during the Egyptian Armed Forces Day, we had the honor
Our team has just placed its very first Teleflex NaviCurve PICC line, marking a new milestone in the development of this practice. As a reminder,
Saint-Joseph and Marie-Lannelongue Hospitals recognized by Newsweek for the 7th Consecutive Year ! The Newsweek World’s Best Specialized Hospitals 2027 ranking once again recognizes the expertise of our